뉴스 검색결과 61건

• 
  HLB Starts Rivoceranib Site Planning to Diversify Supply Chain 2025.04.01
• 
  'Drug Technology Transfer' Bridge Bio·HLB Therapeutics Stocks Surge[K-Bio Pulse] 2025.03.29
• 
  CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 2025.03.27
• 
  계열사 50곳...M&A로 덩치불린 HLB의 목적지는 2025.03.27
• 
  HLB’s NDA Rejected Again; Resubmission in May, FDA Decision by July 2025.03.23
• 
  Alteogen, HLB Plunge on Rumors; A Rough Day for Biotech Stocks[K-bio Pulse] 2025.03.21
• 
  HLB, 美신약허가 또 불발…“오는 5월 재신청, 7월 FDA 허가 기대”(종합) 2025.03.21
• 
  “모 아니면 도” HLB ‘리보세라닙’ 美 허가 어찌될까 2025.03.20
• 
  CellBion Rises as Leading RPT Stock·HLB Group’s 11 Stocks Decline[K-Bio Pulse] 2025.03.15
• 
  Daehwa Pharmaceutical, Anygen Hit Upper Limit; HLB Group Stocks Struggle Amid Rumors[K-Bio Pulse] 2025.03.12